Don’t Miss Alpha-1 Antitrypsin Deficiency: Key Takeaways from the 2025 Canadian Guidelines | Dr. Mohit Bhutani

Dr. Mohit Bhutani summarizes the 2025 Canadian Thoracic Society guidelines, stressing that AATD is underdiagnosed but easy to test for and should be routinely screened in all COPD patients and other at-risk groups. He outlines updated recommendations for diagnosis, family testing, and treatment, including criteria for augmentation therapy, while reinforcing the value of early detection in improving outcomes.

For disease awareness only, not for promotional use. The opinions expressed in this video are those of the speaker and do not necessarily reflect those of Takeda.